APA

Smith J. D., Baillie J., Baglin T., Griffiths G. O., Casbard A., Cohen D., Fitzmaurice D. A., Hood K., Rose P., Cohen A. T., Johnson M., Maraveyas A., Bell J., Toone H., Nelson A. & Noble S. I. (20141021). A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study. : Trials.

Chicago

Smith Joanna D, Baillie Jessica, Baglin Trevor, Griffiths Gareth O, Casbard Angela, Cohen David, Fitzmaurice David A, Hood Kerenza, Rose Peter, Cohen Alexander T, Johnson Miriam, Maraveyas Anthony, Bell John, Toone Harold, Nelson Annmarie and Noble Simon I. 20141021. A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study. : Trials.

Harvard

Smith J. D., Baillie J., Baglin T., Griffiths G. O., Casbard A., Cohen D., Fitzmaurice D. A., Hood K., Rose P., Cohen A. T., Johnson M., Maraveyas A., Bell J., Toone H., Nelson A. and Noble S. I. (20141021). A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study. : Trials.

MLA

Smith Joanna D, Baillie Jessica, Baglin Trevor, Griffiths Gareth O, Casbard Angela, Cohen David, Fitzmaurice David A, Hood Kerenza, Rose Peter, Cohen Alexander T, Johnson Miriam, Maraveyas Anthony, Bell John, Toone Harold, Nelson Annmarie and Noble Simon I. A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study. : Trials. 20141021.